See more : Fenix Outdoor International AG (FOI-B.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Synergy CHC Corp. (SNYR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Synergy CHC Corp., a leading company in the Medical – Distribution industry within the Healthcare sector.
- Topps Tiles Plc (TPT.L) Income Statement Analysis – Financial Results
- Sturm, Ruger & Company, Inc. (RGR) Income Statement Analysis – Financial Results
- Iniziative Bresciane S.p.A. (IB.MI) Income Statement Analysis – Financial Results
- Bharti Airtel Limited (BHARTIARTL.NS) Income Statement Analysis – Financial Results
- Soditech SA (SEC.PA) Income Statement Analysis – Financial Results
Synergy CHC Corp. (SNYR)
About Synergy CHC Corp.
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers under the Hand MD brand name. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. Synergy CHC Corp. was incorporated in 2010 and is based in Westbrook, Maine.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.78M | 38.41M | 0.00 | 40.23M | 29.36M | 33.82M | 35.60M | 34.84M | 13.46M | 9.16K | 0.00 | 0.00 |
| Cost of Revenue | 10.70M | 25.11M | 0.00 | 14.68M | 9.14M | 12.47M | 9.82M | 10.21M | 5.31M | 5.62K | 0.00 | 0.00 |
| Gross Profit | 32.08M | 13.30M | 0.00 | 25.55M | 20.22M | 21.35M | 25.78M | 24.64M | 8.15M | 3.54K | 0.00 | 0.00 |
| Gross Profit Ratio | 74.99% | 34.62% | 0.00% | 63.51% | 68.87% | 63.12% | 72.42% | 70.71% | 60.55% | 38.68% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.05M | 9.20M | 0.00 | 6.50M | 5.49M | 7.19M | 8.42M | 8.02M | 3.37M | 961.64K | 13.28K | 9.00K |
| Selling & Marketing | 15.19M | 28.50M | 0.00 | 15.89M | 11.47M | 16.33M | 14.04M | 10.33M | 3.69M | 0.00 | 0.00 | 0.00 |
| SG&A | 21.24M | 37.92M | 0.00 | 22.46M | 16.97M | 23.52M | 22.46M | 18.35M | 7.05M | 961.64K | 13.28K | 9.00K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 1.21M | 27.79K | 212.77K | 1.17M | 608.00K | 0.00 | 8.50K | 0.00 |
| Operating Expenses | 21.27M | 39.45M | 0.00 | 22.46M | 18.18M | 25.34M | 23.96M | 19.52M | 7.66M | 961.64K | 21.78K | 9.00K |
| Cost & Expenses | 31.97M | 64.56M | 0.00 | 37.14M | 27.31M | 37.82M | 33.77M | 29.73M | 12.97M | 967.25K | 21.78K | 9.00K |
| Interest Income | 4.23M | 0.00 | 0.00 | 104.00 | 414.00 | 235.00 | 20.00 | 5.11K | 1.46K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 1.30M | 981.11K | 1.13M | 1.04M | 1.57M | 958.74K | 2.00K | 1.42K | 1.20K |
| Depreciation & Amortization | 33.33K | 340.00K | 236.56K | 100.27K | 1.21M | 1.82M | 1.49M | 1.17M | 608.00K | 849.05K | 43.11K | 12.00K |
| EBITDA | 10.84M | -24.63M | 0.00 | 3.19M | -6.88M | -2.36M | 3.31M | 4.51M | 1.09M | -111.04K | -21.78K | -3.00K |
| EBITDA Ratio | 25.34% | -64.11% | 0.00% | 7.92% | 10.64% | -6.97% | 9.29% | 18.04% | -33.88% | -10,461.83% | 0.00% | 0.00% |
| Operating Income | 10.81M | -24.97M | 0.00 | 3.09M | 1.91M | -4.92M | 1.82M | 2.93M | 486.02K | -958.09K | -21.78K | -15.00K |
| Operating Income Ratio | 25.26% | -65.00% | 0.00% | 7.67% | 6.51% | -14.54% | 5.12% | 8.42% | 3.61% | -10,461.83% | 0.00% | 0.00% |
| Total Other Income/Expenses | -4.23M | -7.63M | 0.00 | -1.67M | -10.83M | -1.49M | -1.01M | -4.96M | -7.63M | -2.00K | -991.00 | -6.00K |
| Income Before Tax | 6.57M | -32.60M | 0.00 | 1.41M | -9.08M | -6.41M | 815.58K | 148.20K | -7.15M | -960.09K | -59.88K | -21.00K |
| Income Before Tax Ratio | 15.37% | -84.87% | 0.00% | 3.51% | -30.92% | -18.95% | 2.29% | 0.43% | -53.11% | -10,483.64% | 0.00% | 0.00% |
| Income Tax Expense | 234.98K | 32.17K | 0.00 | -5.00 | 131.54K | -247.69K | 316.01K | 944.36K | 389.95K | -849.05K | 23.20K | 1.20K |
| Net Income | 6.34M | -32.63M | 0.00 | 1.41M | -9.21M | -6.16M | 499.57K | -796.16K | -7.54M | -960.09K | -23.20K | -16.20K |
| Net Income Ratio | 14.82% | -84.95% | 0.00% | 3.51% | -31.36% | -18.21% | 1.40% | -2.29% | -56.01% | -10,483.64% | 0.00% | 0.00% |
| EPS | 0.07 | -0.36 | 0.00 | 0.02 | -0.10 | -0.07 | 0.01 | -0.01 | -0.11 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.07 | -0.36 | 0.00 | 0.02 | -0.10 | -0.07 | 0.01 | -0.01 | -0.11 | -0.01 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 90.55M | 89.89M | 0.00 | 89.89M | 89.88M | 89.86M | 89.24M | 81.65M | 68.85M | 97.17M | 152.90M | 150.00M |
| Weighted Avg Shares Out (Dil) | 89.89M | 89.89M | 0.00 | 89.89M | 89.88M | 89.86M | 89.24M | 81.65M | 68.85M | 97.17M | 152.90M | 150.00M |
U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names
Synergy CHC Corp. Announces Closing of Initial Public Offering
Synergy CHC Corp. Prices $10.35 Million Initial Public Offering
Source: https://incomestatements.info
Category: Stock Reports